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The development of multicellular organisms requires precise spatiotemporal gene expression and the expression of cell/tissue specific isoforms
of some genes. This task may require more efficient genome organization in Caenorhabditis elegans and other organisms with relatively small
genome size. The SL1 leader sequence is trans-spliced to many mRNAs in C. elegans. We hypothesize that introns coupled to internal SL1
acceptors contain independent promoters. We identify 238 genes that have introns coupled to internal SL1 acceptors. We find that the mean length
of the internal SL1-coupled introns is significantly longer than the genome mean. For twelve of the genes, evidence exists that the intronic
promoter provides tissue specificity different from that of the primary promoter. We estimate that 2.7% of the genome is regulated through this
two-promoter system. We propose that internal SL1-coupled introns function as independent promoters and that this two-promoter system
represents a major mechanism in C. elegans, in addition to alternative splicing, that serves to promote tissue-specific expression of protein
isoforms. Our finding of the frequent coupling between an internal SL1 and a large immediately upstream intron will make promoters and
transcription start sites predictable.
© 2006 Elsevier Inc. All rights reserved.Keywords: Two-promoter system; Internal SL1; Intronic promoter; Gene expression; Protein diversity; nsf-1; C. elegansIntroduction
The development of multicellular organisms requires precise
spatial and temporal gene expression as well as the expression
of a variety of cell/tissue specific isoforms of some genes. A
general way to tightly control the timing and location of gene
expression is to use multiple enhancers/repressors; these can be
located within promoters, introns, and regions downstream of
the regulated genes. The creation of cell/tissue specific protein
variants is generally accomplished by alternative splicing, the
expression of paralogous genes, and sometimes, post-transcrip-
tional RNA editing. Both of the above sets of tasks may require
more efficient genome organization in C. elegans and other
organisms with relatively small genome size. To date, the role of
introns in creating protein isoforms has not been addressed.
Gene expression and mRNA processing in C. elegans have
some features that distinguish this metazoan from many others.
First, 42.6% of pre-mRNAs can be spliced in trans (see⁎ Corresponding author. Fax: +1 713 796 9438.
E-mail address: apnewman@uh.edu (A.P. Newman).
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doi:10.1016/j.ydbio.2006.04.470Materials and methods) as well as in cis. Cis-splicing occurs
between two exons and trans-splicing between SL1 (spliced
leader 1), which is supplied from SL1 RNA, and an exon.
Second, some genes are expressed in a common operon. In this
case, all genes except the first in the operon are generally trans-
spliced to SL2 (spliced leader 2) rather than SL1 (Blumenthal et
al., 2002). Third, while alternative splicing is known to occur in
C. elegans, it is relatively rare (14.2%) (WormBase WS153
release notes).
Principles and features of both cis- and trans-splicing are
generally the same. However, insertion of an intronic sequence
containing only a 3′ splice site upstream of the first exon of a
gene that is not normally trans-spliced to SL1 causes the
transcript to undergo trans-splicing (Conrad et al., 1991). In
addition, insertion of a 5′ splice site upstream of a first exon that
is supposed to be trans-spliced to SL1 inhibits trans-splicing
(Conrad et al., 1993). Thus, the presence or absence of a 5′
splice donor can determine whether trans-splicing will occur
(Conrad et al., 1991, 1993).
We have recently shown that the C. elegans nsf-1 gene
expresses two transcripts under the control of two distinct
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spliced (we refer to this SL1 as an internal SL1 since it is
spliced to an exon other than the first) and its coding
sequences are preceded by a long intron. The long intron
(intron 2) of nsf-1, which is coupled to an internal SL1,Fig. 1. C. elegans uses the two-promoter system to promote protein diversity in genes
products. In addition to the 5′ upstream promoter (P1), an intron (IN2) that is coupled
we have not included sequences past the fourth exon. (B) A model for the two-pro
transcripts illustrates the effect on trans-splicing of the start point of the shorter transc
The longer isoform is made from transcript L. The first exon of this transcript can be ei
isoform in this figure is predicted to be trans-spliced to an internal SL1 only if the ups
the transcript. In this case, only transcript S-4 is predicted to be trans-spliced. Since
coupled to an internal SL1, the intron is expected to contain an independent promoter f
an intronic promoter (IN1) make up the two-promoter system. When both the two-pro
number of protein isoforms resulting from alternative splicing will be doubled due to
(2 × 2 = 4). L: longer transcript, S: shorter transcript, P1: promoter 1, a convention
region, EX: exon, IN: intron, TBP: TATA-binding protein, GTF: general transcription
Green lines indicate internal SL1s. Green inverted triangles indicate internal SL1 acfunctions as a separate promoter for the shorter transcript nsf-
1s (Fig. 1A) (Choi et al., in press).
In this study, we investigated whether other genes might be
regulated in a similar manner. We initially hypothesized that the
transcription start sites of the shorter transcripts, which undergoincluding nsf-1. (A) Shown is the structure of nsf-1 and its primary transcription
to an internal SL1 functions as a promoter for the shorter isoform. For simplicity,
moter system. Structure of hypothetical gene and long (L) and short (S-1–S-4)
ript. All the transcription products shown are primary RNAs not mature mRNAs.
ther trans-spliced to an SL1 (external SL1) or not (Zorio et al., 1994). The shorter
tream 5′-splice site (red diamond) of intron 1 (blue dashed line) is not included in
the transcription start site of the shorter isoform is predicted to be in the intron
or expression of the shorter isoform. A conventional upstream promoter (P1) and
moter system and alternative splicing occur at the same gene locus, the possible
the two-promoter system; in this figure, the number of protein isoforms will be 4
al upstream promoter, P2: promoter 2, an intronic promoter, UTR: untranslated
factors, PolII: RNA polymerase II. Black arrows indicate transcription start sites.
ceptors. Red diamonds indicate the upstream 5′-splice sites.
Table 1
Genes with experimentally determined regulation by the two-promoter system
Gene ID Gene name Isoform Experiment
B0491.8 clh-2 c GFP reporter
C01G6.8 cam-1/kin-8 b GFP reporter
C01H6.5 nhr-23 b LacZ and GFP reporters
C18A11.7 dim-1 b GFP reporter and Anti-GFP antibody
C36B1.1 cle-1 c GFP reporter
F38B2.1 ifa-1 c* GFP reporter
F45E10.1 unc-53 e GFP reporter
F49E11.1 mbk-2 a GFP reporter
F55A8.2 egl-4 c GFP reporter
W02C12.3 unassigned a and f GFP reporter
Y105E8B.1 lev-11 c and e LacZ and GFP reporters
ZK899.8 gap-2 c GFP::lacZ reporter
The isoform column reports the isoform(s) of each gene generated by an internal
promoter. Isoforms are as named in WormBase. The one exception is followed
by an asterisk; in this case, EST data in WormBase and experimental data from a
published report indicated the presence of a third isoform not shown on
WormBase, which we designate as c. The SL1-coupled introns of the isoforms
of genes in black are confirmed both by the EST and mRNA data present in
WormBase and through experimental evidence reported in published papers. For
genes indicated in blue, the data comes from published experimental data only.
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upstream introns of the trans-splice sites so that the upstream
5′ splice sites would not be included in the transcripts (Fig. 1B).
Further, we hypothesized that these introns, which are coupled
to internal SL1, could function as separate promoters. We
expected that these introns would be significantly longer than
other introns since they would function as independent
promoters. We performed a genome-wide analysis by searching
the C. elegans databases. We identified 238 genes whose shorter
transcripts are trans-spliced to internal SL1s. We propose that
these genes might be regulated through the two separate
promoters. We refer to this mechanism of gene regulation as a
two-promoter system—i.e. Expression of the longer isoform is
controlled by 5′ upstream regulatory sequences (a conventional
upstream promoter) while that of the shorter isoform requires
sequences in the upstream introns (an intronic promoter; an
intron coupled to an internal SL1). Our study suggests a
genome-wide mechanism of gene expression in which the
introns coupled to SL1s function as separate promoters, thereby
achieving protein diversity.
Materials and methods
Identification of intronic promoters
To find genes that might have intronic promoters, we searched WormBase
(http://www.wormbase.org, releases WS127 throughWS130, dates July through
October, 2004) and identified genes that had SL1 or isoform in their designation.
A search of all categories yielded 89,375 entries matching “SL1” and 7,352
entries matching “isoform”. To identify genes only (and not antibodies, alleles,
etc), we then selected the subgroup containing the term “CDS (CoDing
Sequence)”; this yielded 1,203 and 714 entries for SL1 and isoform, respectively.
Among these genes we obtained 236 genes containing internal SL1 acceptors
based on ESTand mRNA data onWormBase. Specifically, we first examined the
pictorial representations of EST and mRNA structure on WormBase for the
presence of trans-spliced SL1. We also examined the ESTand mRNA sequences
directly and found some that contained trans-spliced SL1s although this
information was not contained in the pictorial representations. In these cases, we
notified WormBase to update the information. In addition to our search of
WormBase, we searched PubMed (http://www.pubmed.gov, date November,
2004) to obtain published data matching combinations of words, such as
“intron”, “promoter”, “SL1”, and “C. elegans”. Using this latter strategy, we
obtained papers describing the presence of SL1-coupled introns in twelve genes
(see Results and discussion for further information). Two of these genes were not
found through our search of WormBase (Table 1) (their internal SL1-coupled
cDNAs had not been entered intoWormBase), thereby bringing the total number
of genes with internal SL1s to 238. A total of 275 transcripts were obtained since
some genes contain more than one internal SL1 acceptor (see Supplementary
Table 1 for further information).
To calculate the percentage of genes that are trans-spliced to SL1, we used a
GFF (Gene-Finding Format) file, elegansWS153.gff, from WormBase (http://
www.wormbase.org, release WS153, date January, 2006). We obtained 7,657
entries containing ‘SL1’, which corresponds to 42.6% of the total number of
transcripts that have transcript evidence (17,964 out of 22,901; this includes
alternative isoforms of some genes) (WormBase WS153 release notes).
Analysis of the 238 genes
We calculated the mean length of internal SL1-coupled introns of these
genes and compared it to the mean length of all introns in the C. elegans
genome. To obtain the genome mean, we used the same file called
elegansWS153.gff. We obtained and analyzed 123,219 curated introns using
Perl. To obtain the mean length of first exons, we used Perl to analyze 19,847first exons from 146,120 curated exons. We examined whether the first exons of
the longer transcripts contain conserved functional domains using information
on Wormbase, Pfam (http://www.sanger.ac.uk/Software/Pfam) and InterPro
(http://www.ebi.ac.uk/interpro). We also examined whether the protein products
from the shorter and the longer transcripts contain different subcellular
localization signals due to the absence and presence of the first exons followed
by internal SL1-coupled introns. The prediction of subcellular localization was
performed using ESLpred (Bhasin and Raghava, 2004) and ProSLP v2.0 (http://
www.ccbb.re.kr/~proslp, 2006). Information on whether these genes are in an
operon is found on Wormbase.Results and discussion
To determine whether the two-promoter system might apply
to other genes in addition to nsf-1, we searched WormBase (see
Materials and methods). We found 238 genes that, like nsf-1,
contained transcripts with internal SL1s. We found that, for the
introns immediately preceding the internal acceptor, the mean
length (2377.2 bp ± 2671.1; median = 1440 bp) was
significantly longer than the genome mean (320.8 bp ± 737.3;
median = 68 bp) (P < 0.0001; two-tailed one sample t test)
(Supplementary Table 1) (Figs. 2A, B). A dissection of
regulatory sequences has previously been performed for twelve
of these loci; in all cases, the promoter for the internal transcript
(s) is localized to the immediately upstream intron and the
spatial and temporal expression patterns of the shorter isoforms
are distinct from those of the longer ones (Fig. 1A) (Ackley
et al., 2001; Anyanful et al., 2001; Hayashizaki et al., 1998;
Johnsen et al., 2005; Kagawa et al., 1995; Karabinos et al.,
2003; Koga et al., 1999; Kostrouchova et al., 1998; Nehrke
et al., 2000; Raich et al., 2003; Rogalski et al., 2003; Stansberry
et al., 2001; Stringham et al., 2002) (Table 1). Therefore, we
propose that this is a general mechanism in C. elegans that may
apply to many of the 238 genes.
From the 238 genes discussed above, only 30 (10.9%) of the
transcripts with internal SL1 acceptors have unique exons
Table 2
Classification of the 275 transcripts analyzed in this study by location (in intron
number) of the predicted promoters
Intron number 1 2 3 4 5 6–10 >10 Total
Number of
genes (%)
181
(65.8)
41
(14.9)
13
(4.7)
6
(2.2)
10
(3.6)
16
(5.8)
8
(2.9)
275
There are 275 transcripts from the 238 genes analyzed in this study (see text and
supplementary Table 1 for further information) because some genes produce
multiple internal SL1 trans-spliced transcripts.
Fig. 2. Intron and exon length distribution. (A) Distribution of intron length
within the C. elegans genome. Shown are introns of 30–300 bp which
correspond to 73% of all introns (see Supplementary data for distribution of all
introns). 47.1% of introns are between 41 and 60 bp. Each dot represents introns
within a 10 bp range of lengths. (B) Intron length distribution for the entire
genome (blue) compared with that for the 238 genes analyzed in this paper
(pink). Each dot represents introns within a 1-kb range of lengths. (C) First exon
length distribution for the entire genome (blue) compared to that for the 238
genes analyzed in this study (pink). Each dot represents exons within a 50-bp
range of lengths. Exon length distribution for the entire genome is available in
Supplementary Fig. 1.
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conserved functional domain (Supplementary Table 1). This is
partly because intronic promoters reside mostly in the first twointrons (80.7%) (Table 2). Thus, the isoforms of some of these
genes might be substitutive of each other. Supporting this idea,
the expression of nsf-1s in a cell that normally expresses only
nsf-1l rescued a mutant defect (Choi et al., in press). In addition,
the mean length of the first exons prior to internal SL1-coupled
introns (80.8 bp ± 83.3; median = 62.5 bp; n = 120) is
significantly shorter than the genome mean of the first exons
(171.8 bp ± 193.8; median = 129 bp; n = 19,847) (P < 0.0001;
two-tailed one sample t test) (Fig. 2C). Nevertheless, for 17.2%
of the loci analyzed by ESLpred and 14.3% by ProSLP v2.0, the
additional exons confer on the protein products a distinctive
predicted subcellular localization (Supplementary Table 1).
However, there is little overlap in the results from the two
prediction programs; thus, the significance of this observation is
unclear.
Despite the trend towards longer introns in the two-promoter
system, 56 (20.4%) of the transcripts contain internal SL1-
coupled introns that are shorter than the genome mean.
Moreover, 16 of these (5.8%) are less than 100 bp. However,
it has been shown that promoters of less than 300 bp do exist in
C. elegans, although they are not common; for instance, there
are genes whose minimal promoters lie within 200–300 bp
(Britton et al., 1998; Culetto et al., 1999; Gaudet et al., 1996). In
addition, short introns of 41–60 bp are common in C. elegans
(47.1%) (Fig. 2A). However, the internal SL1-coupled introns
of this length might be too small to function as fully functional
promoters. It is possible that the promoters extend into upstream
sequences including 5′-UTR and exons while the transcription
start sites are within the introns.
While introns have previously been implicated in the
regulation of gene expression, they generally contain
enhancers, not independent promoters. Nevertheless, some
introns have been reported to function as independent
promoters-specifically, those contained in human and mouse
mdm2 (Barak et al., 1994; Liang et al., 2004; Zauberman et
al., 1995), sheep acetyl-CoA carboxylase α gene (Barber and
Travers, 1998), human growth hormone gene (hGH-N) (Kolb
et al., 1998), human bone morphogenetic protein-4 gene (Van
den Wijngaard et al., 1999), mouse p45 NF-E2 gene (Moroni
et al., 2000), human osteoclastic protein-tyrosine phosphatase
(PTP-oc) gene (Amoui et al., 2003), and mammalian RUNX
(Levanon and Groner, 2004). Some of these introns appear
responsible for transcriptional, not translational, variants since
the transcripts expressed by these introns contain the same
coding exons and differ only in 5′-UTRs (untranslated
regions). So far, in only mouse mdm2, human PTP-oc, and
mammalian RUNX have the different promoters been
Table 3
Internal trans-splicing involving genes in operons and/or the SL2 spliced leader
sequence
Gene ID Gene name Isoform First gene in operon? Spliced to internal
SL1, internal SL2,
or both?
C01H6.5 nhr-23 b Y SL1
c*
C07G2.2 atf-7 c N SL1
C07G2.3 cct-5 b Y SL1
C18E3.7 ppw-1 b and c Y SL1
C23G10.2 unassigned c N both
C27H6.4 unassigned c* N SL1
C35D10.7 unassigned b N SL1
C36A4.9 unassigned a and b Not in operon both
C37H5.6 unassigned b N both
C47B2.3 tba-2 b* Y SL1
C47E12.4 unassigned b, c and d Y SL1
D2096.3 unassigned b* N SL1
E04A4.7 unassigned b* N both
F01F1.6 alh-9 b* Y SL1
F02E9.9 unassigned a Y SL1
F09F7.4 unassigned b Y SL1
F10G8.9 unassigned a N SL1
F18A1.6 unassigned c* N SL1
F26F12.3 unassigned c* Y SL1
F27C1.7 unassigned c* Y SL1
F29G9.2 unassigned b N SL1
F36D4.3 hum-2 c Y SL1
f both
F36H2.1 tat-5 a N SL1
F39H2.2 cyp-14 b N SL2
F46E10.9 dpy-11 b Y both
F52C9.8 pqe-1 f N SL1
F53A2.8 mtm-6 b N SL1
F54D5.12 unassigned b* N both
F55A8.1 egl-18 b* Y both
F55B12.3 sel-10 a Y SL1
F57B10.3 unassigned b Not in operon both
F59G1.1 unassigned c N both
d SL1
K08A2.5 nhr-88 b and c Not in operon both
K10C3.6 nhr-49 a N both
T08B2.9 frs-1 b Y SL1
T10E9.7 nuo-2 b Y SL1
T10F2.1 grs-1 b N SL1
T13C5.5 bca-1 a N SL1
T27F7.1 unassigned b* Y SL1
W07A8.3 dnj-25 b* Y SL1
Y43C5A.6 rad-51 b Y SL1
ZK256.1 pmr-1 c N SL1
Isoforms are as named in WormBase. Those not included in WormBase are
given the appropriate letter designation and indicated by an asterisk. The column
“First gene in operon?” indicates whether the gene containing the trans-spliced
isoform is the first gene in the operon. Isoform b of cyp-14 (F39H2.2) has an
internal SL2 acceptor and is not included in our list of 238 genes since it is not
known whether trans-splicing to SL2 requires the absence of a 5′-splice donor
as is the case for SL1. Interestingly, however, the length of this SL2-coupled
intron is about 2.2 kb. Trans-splicing has been considered to utilize SL1 for the
first gene in an operon (if it is trans-spliced) and SL2 or both SL1 and SL2 for all
other genes in an operon (reviewed in Blumenthal, 1995). However, as shown in
this table, when the first gene in an operon has isoforms that result from internal
trans-splicing, these isoforms can be spliced to SL2. These genes are indicated
in bold. In addition, there are three genes indicated in blue that are trans-spliced
to internal SL2s but are not in operons. These are the only genes that are
observed to be trans-spliced to a leader sequence other than SL1 without
involving an operon.
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et al., 2003; Barak et al., 1994; Levanon and Groner, 2004).
By contrast, in C. elegans, 78.5% of the transcripts from the
238 genes in this study give protein variants (Supplementary
Table 1). Other unique features of the putative intronic
promoters in C. elegans are the internal SL1 and the fact that
only 16.4% of the transcripts start with alternative first exons
(Supplementary Table 1). By contrast, in the other organisms
discussed here, all the transcripts expressed by intronic
promoters except mouse mdm2 have been reported to start
with alternative first exons.
The reason that C. elegans uses the mode of gene regulation
discussed here is not clear. However, this mechanism may
facilitate achievement of protein diversity. It is possible that due
to a small genome size of 100 Mb (Chen et al., 2005; The C.
elegans Sequencing Consortium, 1998) compared with about
180 Mb in Drosophila (Adams et al., 2000) and 3000 Mb in
human (Rowen et al., 1997), C. elegans might need more
efficient genome organization, thereby using some introns as
promoters. It is also possible that the two-promoter system
might be necessary to compensate for the low rate of alternative
splicing in this organism (14.2%) (WormBase WS153 release
notes) compared with 40–74% in Drosophila and human,
respectively (Johnson et al., 2003; Stolc et al., 2004). Other
explanations are also possible.
Previously, 540 genes in C. elegans were suggested to
regulate development, through signaling or transcriptional
regulation (Ruvkun and Hobert, 1998). In analyzing the
predicted products of the 238 genes with internal SL1 acceptors,
we found that 16 of them belonged to the group of 540 genes
and that the frequency within 238 was significantly higher than
in the complete genome (P = 0.00127; two-tailed Fisher's Exact
Test) (Supplementary Table 1). These genes might need to be
expressed at specific places at the appropriate times more than
once during development — thus necessitating the mechanism
of regulation described here. Of the 238 genes that we have
identified as regulated by the two-promoter system, some of
them are known to be critical to development. Thus, nsf-1l is
specifically expressed during uterine–vulval development
(Choi et al., in press). In addition, most of the twelve genes
whose intronic promoters have been proven are also required
for development; nhr-3 is essential to epidermal development
(Kostrouchova et al., 1998), lev-11 to body morphology
(Anyanful et al., 2001; Kagawa et al., 1995), dim-1 to bodywall
muscle integrity (Rogalski et al., 2003), cle-1 to cell migration
and axon guidance (Ackley et al., 2001), cam-1 to neuronal
process development (Koga et al., 1999), gap-2 and ifa-1 to
larval development (Hayashizaki ;et al., 1998; Karabinos et al.,
2003), and unc-53 to cell migration and outgrowth (Stringham
et al., 2002).
It is unclear whether the internal SL1 is necessary for this
mode of expression or whether the regulatory regions contained
within the large introns themselves are sufficient. SL1 was
shown to enhance the translation of some synthetic mRNAs,
suggesting that the internal SL1 might be important for
translation initiation (Maroney et al., 1995). Another possibility
is that the internal SL1 functions together with its immediately
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expression. Nonetheless, some C. elegans genes appear to use
two promoters without internal SL1 coupling, as doDrosophila,
mice and humans (see above). For example, the ser-2 gene has
an independent promoter for the shorter isoform in intron 1 (Rex
et al., 2004; Tsalik et al., 2003). In addition, the crm-1 gene is
not trans-spliced to an internal SL1 although the existence of
multiple cDNAs coding for the same short isoform (WormBase)
suggests that intron 2 might be an additional promoter.
Interestingly, the relevant introns in both of the above genes
are about 3 kb in length. The fact that the introns that appear to
contain internal promoters are substantially longer than the
genome mean (mean lengths of 2377.2 bp and 320.8 bp,
respectively) suggests a useful strategy for identifying potential
two-promoter genes that are not SL1-spliced. Specifically, since
93.2% of C. elegans introns are 1 kb or shorter, it might be
useful to examine those that are longer than 1 kb using promoter
prediction programs and to test for the existence of separate
promoters using reporter constructs.
The detection of internal SL1 acceptors in this study
depends on the EST and mRNA databases on WormBase. The
EST and mRNA clones available on WormBase are not
saturated to show all kinds of transcripts of each gene, and
more importantly, the databases do not show EST clones of at
least 21.6% of the C. elegans genes (WormBase WS153
release notes). Thus, we anticipate that the total number of
genes regulated by the mechanism described here will be much
higher than 238. In fact, Sternberg and colleagues obtained
transcripts containing SL1 using TEC-RED (trans-spliced
exon coupled RNA end determination) (Hwang et al., 2004).
Among 1597 SL1 trans-spliced transcripts, 102 (6.4%) had
internal SL1 acceptors (Hwang et al., 2004). Since we estimate
that 42.6% of C. elegans genes are trans-spliced to SL1 (see
Materials and methods), the total number of genes with
internal SL1 acceptors might be around 547, or about 2.7% of
the genome (20,057 × 42.6% × 6.4% = 546.8). Therefore, a
false negative rate for our search would be 56.5%: false
negative/(true positive + false negative) × 100% = (547–238)/
547 × 100% = 56.5%.
We calculated the mean number of cDNA clones per gene for
our list of 238 genes and for the initial sample of 1,203 SL1
CDS and 714 isoform CDS (see Materials and methods) by
selecting the first 100 genes from each list. The mean of the
former was 30.03 ± 40.15 and the latter 15.68 ± 23.53
(P = 0.0005; two-tailed one sample t test), suggesting that the
high false negative rate might be due to a lack of saturated EST
and mRNA data in WormBase. The estimated percentage of
genes that generates multiple protein isoforms through
alternative splicing (up to 14.2%) and the two-promoter system
(2.7%) is around 16.9% in the C. elegans genome. This
proportion is still relatively very low compared to other
organisms, such as Drosophila (40%) and human (74%). This
is partly because the C. elegans alternative splicing rate was
generated using current EST data, which is far from
completeness and saturation. For Drosophila and human, the
previous estimates of alternative splicing based on EST and
cDNA data were 20% and 38%, respectively (Brett et al., 2000;Celniker and Rubin, 2003). These numbers are about half of the
current estimates, which are based on microarray analyses using
splice junction probes (Johnson et al., 2003; Stolc et al., 2004).
Thus, the actual rate of alternative splicing in C. elegans is
likely to be substantially higher than 14.2%. In addition, the
number of genes in C. elegans (about 20,000) (see Materials
and methods) surpasses that of Drosophila (around 14,000)
(reviewed in Graveley, 2001). This might also explain the lower
rate of alternative splicing in C. elegans. Moreover, C. elegans
is a much simpler organism than Drosophila, and might
therefore need a less abundant proteome.
C. elegans contains operons, in which downstream gene(s)
in an initial polycistronic pre-mRNA are generally trans-spliced
to SL2 (Blumenthal et al., 2002). Interestingly, some of the 238
genes discussed here are predicted to be in operons (Table 3 and
Supplementary Table 1) (Blumenthal et al., 2002), and are
trans-spliced to SL1 rather than SL2, or to either SL1 or SL2.
Based on our findings, we hypothesize that these genes might
be transcribed separately as well as co-transcribed in operons.
This will be an interesting area for future investigation.
Our study is the first report of genome-wide internal
promoter prediction. Internal SL1-coupled introns are very
likely to function as independent promoters to produce protein
isoforms. At least 13 examples have been individually
demonstrated. This two-promoter system probably represents
another major mechanism in C. elegans promoting protein
diversity. Identifying promoters and transcription start sites of
genes is crucial for understanding when and where those genes
act as well as their functions. Our finding of the frequent
coupling between an internal SL1 and a large immediately
upstream intron will facilitate this process by making promoters
and transcription start sites predictable.
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